Blood clot risk much higher from Covid-19, says study

A latest study has said the risk of developing adverse events such as blood clots is considerably higher after infection with the SARS-CoV-2 virus than after immunisation with Pfizer and AstraZeneca Covid-19 vaccines. Continue Reading

WHO’s safety review of AstraZeneca vax underway

WHO Director-General Tedros Adhanom Ghebreyesus emphasized that the WHO’s Global Advisory Committee on Vaccine Safety has been reviewing the available data, is in close contact with the European Medicines Agency (EMA). Continue Reading

Covid-19 vaccine won’t be available for all until 2024: Serum Institute chief

At a time when the whole country is waiting with bated breath for Covid-19 vaccine, Adar Poonawalla, the CEO of Serum Institute, the world’s largest vaccine manufacturer, has come up with a shocker. Continue Reading